Bensch Research Associates

Stockton, California CA 95207

0 studies enrolling now · 22 studies all time

What they study most

Allergic Rhinitis, Asthma, Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis

Studies at this site

• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
• A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Stopped early
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma — Completed
• A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma — Completed
• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR) — Completed
• 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma — Stopped early
• Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients — Stopped early
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis — Completed
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma — Completed
• Study of Daclizumab in Patients With Chronic, Persistent Asthma — Completed
• Pilot Study in Patients With Symptomatic Steroid-Naive Asthma — Completed
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed
• A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed